* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Ypsomed Holding AG's PEG Ratio or its related term are showing as below:
XSWX:YPSN'
s PEG Ratio Range Over the Past 10 Years
Min: 0.98 Med: 4.27 Max: 37.26
Current: 23.17
During the past 13 years, Ypsomed Holding AG's highest PEG Ratio was 37.26. The lowest was 0.98. And the median was 4.27.
XSWX:YPSN's PEG Ratio is ranked worse than 95.9% of 244
companies
in the Medical Devices & Instruments industry
Industry Median: 1.945
vs XSWX:YPSN: 23.17
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Ypsomed Holding AG PEG Ratio Historical Data
The historical data trend for Ypsomed Holding AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ypsomed Holding AG's PEG Ratio
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's PEG Ratio falls into.
Ypsomed Holding AG PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Ypsomed Holding AG (XSWX:YPSN) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Ypsomed Holding AG PEG Ratio Related Terms
Thank you for viewing the detailed overview of Ypsomed Holding AG's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Ypsomed Holding AG (XSWX:YPSN) Business Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:YPSN has been successfully added to your 